BMRN - Biomarin Pharmaceutical Inc.

-

$undefined

N/A

(N/A)

Biomarin Pharmaceutical Inc. NASDAQ:BMRN BioMarin is a global biotechnology company that develops and commercializes innovative therapies for serious and life-threatening rare and ultra-rare genetic diseases. The Company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.

Location: 105 Digital Dr, California, 94949-8703, US | Website: www.biomarin.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

12.37B

Cash

1.138B

Avg Qtr Burn

N/A

Short % of Float

2.67%

Insider Ownership

0.96%

Institutional Own.

98.67%

Qtr Updated

12/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Quarterly sales

VOXZOGO (vosoritide) Details
Achondroplasia, Genetic Short Stature Conditions

Approved

Quarterly sales

VOXZOGO (vosoritide) Details
Achondroplasia, Genetic Short Stature Conditions

Approved

Quarterly sales

BLA

Submission

VOXZOGO Details
Hypochondroplasia

Phase 2

Data readout